Active10571823Private limited companyHull

TRAFALGAR PHARMA LTD

Significant control: Rui Guo (significant control), Rmbx Limited (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Trafalgar Pharma Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Trafalgar Pharma Ltd sell?

Registered activity: Wholesale of pharmaceutical goods (SIC 46460). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

TRAFALGAR PHARMA LTD is an active private limited company (company number 10571823) incorporated on 19 January 2017, registered in Hull. Its registered activity is wholesale of pharmaceutical goods (SIC 46460). Latest abridged accounts cover the period ending 24 July 2025, showing net assets of −£55k and cash of £2,531, with 0 employees on average. As abridged accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets fell 4% on the prior period (−£52k).

Peer position · net assets

By net assets it sits in the bottom quarter of 181 comparable companies in Other (median £10k, upper quartile £324k).

02

Ownership and control

2 active · 2 other
  • Mr Rui Guo
    Individual · since 25 July 2019
    • has significant influence or control
  • Rmbx Limited
    corporate entity, United Kingdom · since 26 July 2019
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Mr Colin Dyer
    Individual · since 19 January 2017 · ceased 21 October 2019
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors
  • Dr Weeliat Chong
    Individual · since 19 January 2017 · ceased 21 October 2019
    • owns 25–50% of shares
    • holds 25–50% of voting rights
    • can appoint or remove directors

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
19 January 20179 yrs ago
Next accounts due
24 April 2027in 181 days
Confirmation statement due
2 February 2027in 100 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 46460
Wholesale of pharmaceutical goods
Accounts type
Unaudited Abridged
Size band
MicroCompanies Act thresholds
05

Financials

2 periods on record · latest ending 24 July 2025
Net assets
−£55k
vs Jul 2024
Cash at bank
£2,531
−33%vs Jul 2024
Turnover
Not disclosed
Employees
0
vs Jul 2024
Net assets
−£55k
Cash at bank
£2,531
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
24 July 2025−£55k£2,531£8,996£600——0
24 July 2024−£52k£3,784£9,710£600——0
Current ratio19.21Current assets ÷ creditors within one year

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets below zeroNet assets £-54,556 at 24 July 2025
  • Current assets at least 1.5× creditors within one yearCurrent ratio 19.21
  • Incorporated five or more years agoIncorporated 19 January 2017

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 181 days
  2. Confirmation statement duein 100 days
  3. Accounts period endNet liabilities £55k · abridged accounts
  4. Accounts period endNet liabilities £52k · abridged accounts
  5. Incorporated
08

Similar companies in the UK

Same activity (wholesale of pharmaceutical goods), closest in incorporation date
09

Reminders for TRAFALGAR PHARMA LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.